http://med.kg/ru/novosti/4817-teper-patsienty-s-onkozabolevaniyami-smogut-poluchat-luchevuyu-terapiyu-s-pomoshchyu-linejnykh-uskoritelej.html
On July 7, 2021, the National Center of Oncology and Hematology held a ceremony of launching linear accelerators.
The event was attended by the Minister of Health and Social Development of the Kyrgyz Republic Alymkadyr Beishenaliev and the staff of the Oncology Center.
The purchase of expensive medical equipment was made at the expense of funds allocated by Kumtor Gold Company CJSC. Two linear accelerators, a computer tomograph and other necessary equipment were purchased with the allocated funds of seven million US dollars.
“This was the first such large purchase by the government. Our goal is to improve the availability and quality of oncological care for the population of the Kyrgyz Republic, to reduce morbidity and mortality from malignant neoplasms. With the commissioning of linear accelerators, the quality of medical care for cancer patients will improve,” said Alymkadyr Beishenaliyev.
According to the management of the Oncology Center, in 2017, $7 million was allocated from the funds of KumtorGoldCompany CJSC for the purchase of expensive equipment, including the purchase of two linear accelerators for the NCOG. In February 2019, the procurement tender procedure was finalized. As a result of the tender, the supplier MN Medikal (Estonia) won the tender and delivered two linear accelerators in the amount of USD 3,874,778.
Under the terms of the contract, two bunkers were overhauled for the installation of the linear accelerators with appropriate radiation safety requirements. The bunkers are closed by automatic doors made of steel and lead. A new CT scanner and other necessary equipment has been purchased specifically for the accelerators and is in operation.
The delivery of the equipment was delayed until the month of October 2020 due to the pandemic and major bunker repairs. The equipment arrived on October 24, 2020. Such equipment is used in Russia, Uzbekistan and Europe. The supplier is one of the leading manufacturers in the world. From the moment the accelerators are put into operation, 3 years of warranty free maintenance is provided, on the doors – 2 years.
“Previously, radiation therapy (remote gamma therapy) was carried out on the TERABALT device (Kyrgyzstan received it under the IAEA project), which worked out its term and was dismantled. Now radiation therapy of patients with malignant neoplasms is carried out with the help of a remote gamma-therapeutic apparatus “Babatron”, donated by India. Both gamma-therapeutic apparatuses worked with radioactive source (cobalt-60). Linear accelerators allows to carry out radiation therapy more accurately, i.e. the maximum dose of radiation falls on the tumor, with minimal radiation load on the surrounding normal tissues, which reduces radiation reactions and radiation damage, which is very important. The two kits purchased are absolutely identical. In the event of a breakdown of one of them, the patient can safely continue treatment on the second one. During one 6-hour shift, up to 40 patients will pass through one accelerator,” said Bakyt Shaimbetov, deputy director of the NCOIG.
Also in the NCOIG noted that currently experts from Moscow, Minsk and the Baltic States are training staff (medical physicists, engineers, doctors and laboratory technicians (nurses)) in Bishkek. Next, they will be sent for internship abroad in Minsk. After the internship, at the end of July, the doctors will start receiving their first patients.
For information:
Cancer diseases are among the main non-communicable diseases that determine the mortality of the world’s population. As in many countries, in the Kyrgyz Republic oncological diseases are one of the main causes of mortality, occupying the second place in the structure of total mortality after cardiovascular diseases. More than 5,000 cases of the disease are registered annually, and the proportion of persons detected with advanced forms of the disease remains high.
Specialized oncological care in the country is provided by the National Center of Oncology and Hematology (NCOH) with 470 beds, Osh Interregional Center of Oncology with 100 beds, oncology departments in Jalal-Abad Regional United Clinical Hospital with 30 beds, in Issyk-Kul Regional General Hospital with 10 beds and in Tokmok Territorial Hospital with 15 beds.
In 2020, 5,377 cancer patients were registered for the first time in the Kyrgyz Republic, and 3,539 died. In the structure of cancer morbidity among the male population, the first place is occupied by stomach cancer – 15.2%, the second place – lung cancer (10.9%), the third place – cancer of the liver and intrahepatic bile ducts (6.2%), the fourth place – prostate cancer (3.7%).
In the structure of oncologic morbidity among the female population, the first place is occupied by breast cancer (18.5%), the second place is occupied by cervical cancer (13.0%), the third place is occupied by stomach cancer (6.1%), and the fourth place is occupied by ovarian cancer (4.8%).
The first place in the structure of mortality in CR is occupied by breast cancer (8.9%), the second place – stomach cancer (8.7%), the third place – cervical cancer (7.3%) and the fourth place – lung cancer (6.3%). By region, the highest rates of breast cancer (18.3%), cervical cancer (12.4%) and stomach cancer (10.8%) are observed in Chui oblast, stomach cancer (17.5%) in Naryn and Talas oblasts (14.1%).
In terms of early diagnosis, the worst situation is in lung cancer (1-2 stages 10.1%, stomach (10.7%) and esophagus (11.4%).
